Search International and National Patent Collections

1. (WO2001032216) PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE

Pub. No.:    WO/2001/032216    International Application No.:    PCT/FR2000/003066
Publication Date: Fri May 11 01:59:59 CEST 2001 International Filing Date: Sat Nov 04 00:59:59 CET 2000
IPC: A61K 31/155
A61K 31/343
A61K 31/36
A61K 31/416
A61K 31/427
A61K 31/473
A61K 45/00
A61K 45/06
A61P 1/00
A61P 1/08
A61P 1/10
A61P 1/12
A61P 3/00
A61P 9/00
A61P 9/10
A61P 9/12
A61P 11/00
A61P 13/12
A61P 17/00
A61P 17/02
A61P 17/06
A61P 17/16
A61P 19/00
A61P 19/02
A61P 19/04
A61P 21/00
A61P 25/00
A61P 25/02
A61P 25/28
A61P 27/00
A61P 29/00
A61P 31/00
A61P 31/12
A61P 31/18
A61P 33/00
A61P 35/00
A61P 37/00
A61P 37/06
A61P 41/00
A61P 43/00
Applicants: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
AUGUET, Michel
CHABRIER DE LASSAUNIERE, Pierre-Etienne
Inventors: AUGUET, Michel
CHABRIER DE LASSAUNIERE, Pierre-Etienne
Title: PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE
Abstract:
The invention concerns a product comprising at least a NO synthase inhibiting substance associated with at least a phospholipase A2 inhibiting substance, separately or combined, for simultaneous therapeutic use, separately or spread over time for treating pathologies in which nitrogen monoxide and/or phosplipases A2 are involved. The invention also concerns a pharmaceutical composition comprising, as active principle, at least a NO synthase inhibiting substance and at least a phospholipase A2 inhibiting substance, and optionally a pharmaceutically acceptable carrier.